این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 20 آذر 1404
Iranian Journal of Basic Medical Sciences
، جلد ۱۹، شماره ۴، صفحات ۴۲۳-۴۲۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Inhibitory effect of clemastine on P-glycoprotein expression and function: an in vitro and in situ study
چکیده انگلیسی مقاله
Objective(s):Transporters have an important role in pharmacokinetics of drugs. Inhibition or induction of drug transporters activity can affect drug absorption, safety, and efficacy. P-glycoprotein (P-gp) is the most important membrane transporter that is responsible for active efflux of drugs. It is important to understand which drugs are substrates, inhibitors, or inducers of P-gp to minimize or avoid unwanted interactions. The aim of this study was to investigate the effects of clemastine on the expression and function of P-gp. Materials and Methods: The effect of clemastine on P-gp function and expression was evaluated in vitro byrhodamine-123 (Rho123) efflux assay in Caco-2 cells and Western blot analysis. Rat in situ single pass intestinal permeability model was used to investigate the clemastine effect on digoxin Peff, as a known P-gp substrate. Digoxin levels in intestinal perfusates were assayed by high performance liquid chromatography (HPLC) method. Results:The Caco-2 intracellular accumulation of Rho123 in clemastine and verapamil treated cells was 90.8 ± 9.8 and 420.6±25.4 pg/mg protein, respectively which was significantly higher than that in control cells (50.2±6.0; P< 0.05). Immunoblotting results indicated that clemastine decreased expression of P-gp in Caco-2 cells in vitro. More over effective intestinal permeability (Peff) of digoxin in the presence of clemastine, was significantly increased compare to control group. Conclusion: Findings of our study suggested dose dependent P-gp inhibition activity for clemastine in vitro and in situ. Therefore co-administration of clemastine with P-gp substrates may result in unwanted interactions and side effects.
کلیدواژههای انگلیسی مقاله
Clemastine, Digoxin, Intestinal Absorption, P-glycoprotein
نویسندگان مقاله
مهران مسگری عباسی | mehran mesgari abbasi
drug applied research center, tabriz university of medical sciences, tabriz, iran|students research committee, tabriz university of medical sciences, tabriz, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
هادی ولی زاده | hadi valizadeh
drug applied research center, tabriz university of medical sciences, tabriz, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
حامد همیشه کار | hamed hamishekar
drug applied research center, tabriz university of medical sciences, tabriz, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
لیلا محمدنژاد | leila mohammadnejad
immunology research center, tabriz university of medical sciences, tabriz, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
پروین ذاکری میلانی | parvin zakeri milani
liver and gastrointestinal diseases research center and faculty of pharmacy, tabriz university of medical sciences, tabriz, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
نشانی اینترنتی
http://ijbms.mums.ac.ir/article_6815.html
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات